Subcutaneous or Transvenous Defibrillator Therapy.
Reinoud E KnopsLouise R A Olde NordkampPeter-Paul H M DelnoyLucas V A BoersmaJürgen KuschykMikhael F El-ChamiHendrik BonnemeierElijah R BehrTom F BrouwerStefan KääbSuneet MittalAnne-Floor B E QuastLonneke SmedingWilleke van der StuijtAnouk de WegerKoen C de WildeNick R BijsterveldSergio RichterMarc A BrouwerJoris R de GrootKirsten M KooimanPier D LambiasePetr NeuzilKevin VernooyMarco AlingsTim R BettsFrank A L E BrackeMartin C BurkeJonas S S G de JongDavid J WrightJan G P TijssenArthur A M Wildenull nullPublished in: The New England journal of medicine (2020)
In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks. (Funded by Boston Scientific; PRAETORIAN ClinicalTrials.gov number, NCT01296022.).